ASHP Midyear 2025 Clinical Meeting & Exhibition: Location, Dates, What to Expect, and What’s Happeninghttps://shieldshealthsolutions.com/content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Every year, more than 20,000 professionals gather for the ASHP Midyear Clinical Meeting & Exhibition. Now in its 60th year, the Midyear Clinical Meeting remains the can’t-miss event where pharmacy’s…
Optimizing Oncology Outcomes: The Impact of Pharmacist-Led Clinical Interventionshttps://shieldshealthsolutions.com/content/uploads/2024/11/white-papers.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Cancer care is complex. For patients prescribed oral oncolytics, managing side effects, staying on schedule, and coordinating care can be overwhelming. These challenges often lead to missed doses, therapy interruptions,…
Shields PGY1 Community-Based Residency Programhttps://shieldshealthsolutions.com/content/uploads/2024/11/blog.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Launch Your Specialty Pharmacy Career with Expert Mentorship and Real-World Experience Are you a pharmacy student or recent graduate looking to elevate your career? The Shields PGY1 Community-Based Residency Program…
The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Carehttps://shieldshealthsolutions.com/content/uploads/2024/11/white-papers.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Unlock Better Outcomes in Cardiometabolic Disease Care Cardiometabolic disease (CMD) is one of the most pressing healthcare challenges of our time—driving trillions in costs and impacting millions of lives. From diabetes…
Shields Health Solutions Advances Health System-Focused Specialty Pharmacy Strategy As A Private Standalone Company Following Acquisition By Sycamore Partnershttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Shields Health Solutions (“Shields” or the “Company”), the premier specialty pharmacy accelerator in the country, announced today that it is now operating as a private standalone company following its acquisition…
NASP 2025 Annual Meeting & Expo: Location, Dates, What to Expect, and What’s Happeninghttps://shieldshealthsolutions.com/content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Each year, NASP members, industry thought leaders, and healthcare veterans from around the country come together to shape the future of specialty pharmacy and the patient journey. Join us to…
Artificial Intelligence in Specialty Pharmacy: Innovation That Empowers, Not Replaceshttps://shieldshealthsolutions.com/content/uploads/2024/11/blog.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Will AI replace pharmacists and technicians? It’s a question that has sparked both curiosity and concern across the healthcare landscape, and understandably so, as artificial intelligence (AI) has already had…
Ambulatory Clinical Pharmacist Impact on Coverage Outcomes for Specialty Oncology Medicationshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the cimpact of an ACP program on third party pharmacy coverage determination outcomes for specialty oncology medications prescribed from these clinics.
Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Programhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led HCM clinical management program.
Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg